引用本文:马小芹,何光照.[cn_title][J].[journal_cn_name],2020,[volume]([issue]):126-128.[点击复制]
Ma Xiaoqin,HE Guangzhao.[en_title][J].[journal_en_name],2020,[volume]([issue]):126-128.[点击复制]
【打印本页】 【在线阅读全文】【下载PDF全文】 查看/发表评论下载PDF阅读器关闭

←前一篇|后一篇→

过刊浏览    高级检索

本文已被:浏览次   下载< /font>次 本文二维码信息
码上扫一扫!
一例肺癌患者使用纳武利尤单抗发生罕见抽搐不良反应的护理
马小芹,何光照
0
(常州市第四人民医院)
摘要:
纳武利尤单抗 (Nivolumab)是百时美施贵宝公司生产的新型抗肿瘤免疫治疗药物,该药物常见的不良反应有疲劳、皮疹、瘙痒、腹泻、恶心、甲亢、甲减等,现报道在常州市第四人民医院发生的1例输注纳武利尤单抗导致罕见的全身抽搐反应,经过积极治疗与护理,顺利完成免疫治疗的过程。
关键词:  肺癌  纳武利尤单抗  抽搐  不良反应  护理
DOI:
基金项目:常州市卫生健康委指导性科技项目(WZ201919)
Nuring experience of lung cancer patients suffering from rare adverse reactions caused by Nivolumab:A case report
Ma Xiaoqin,HE Guangzhao
(Changzhou fourth people’s hospital)
Abstract:
Nivolumab is a new anti-tumor immunotherapy drug produced by Bristol-Myers Squibb Company with adverse reactions of fatigue, rash, itching, diarrhea, nausea, hyperthyroidism and hypothyroidism- The nursing experience of a case with Nivolumab using in Changzhou Fourth Peoples Hospital who resulted in rare reaction of convulsion will introduced in this article.
Key words:  Lung cancer  Nivolumab  Convulsion  Adverse reactions  Nursing

用微信扫一扫

用微信扫一扫